{"entity":{"type":"insider","cik":"0001265801","url":"/insider/0001265801","json_url":"/insider/0001265801.json","name":"PHILLIPS BARCLAY A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":19,"first":"2003-11-06","last":"2018-11-16","span_basis":"filed_date"},"name_variants":[{"name":"PHILLIPS BARCLAY A","source":"filing","n_filings":19,"first_seen":"2003-11-06","last_seen":"2018-11-16"}],"transactions":[{"id":6889722,"accession":"0001562180-18-004597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-004597","line_url":"/filing/0001562180-18-004597#line-2","is_derivative":false,"issuer_cik":"0001265801","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001265801","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":39.9182,"price_display":"39.92","price_state":"stated","total_value":199591.0,"total_display":"199,591.00","total_whole":"199,591","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-16","scope":"insider"},{"id":5209572,"accession":"0001209191-17-046949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-046949","line_url":"/filing/0001209191-17-046949#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2057.0,"shares_display":"2,057","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":1830.73,"total_display":"1,830.73","total_whole":"1,831","shares_owned_after":38669.0,"shares_owned_after_display":"38,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-01","scope":"insider"},{"id":5118798,"accession":"0001209191-17-031437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-031437","line_url":"/filing/0001209191-17-031437#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.838,"price_display":"0.84","price_state":"stated","total_value":20950.0,"total_display":"20,950.00","total_whole":"20,950","shares_owned_after":36612.0,"shares_owned_after_display":"36,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-11","scope":"insider"},{"id":4775017,"accession":"0001209191-17-007070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-007070","line_url":"/filing/0001209191-17-007070#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1633.0,"shares_display":"1,633","price_per_share":1.12,"price_display":"1.12","price_state":"stated","total_value":1828.96,"total_display":"1,828.96","total_whole":"1,829","shares_owned_after":11612.0,"shares_owned_after_display":"11,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-31","filed_date":"2017-02-02","scope":"insider"},{"id":3256716,"accession":"0001209191-16-135041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-135041","line_url":"/filing/0001209191-16-135041#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":422.0,"shares_display":"422","price_per_share":4.29,"price_display":"4.29","price_state":"stated","total_value":1810.38,"total_display":"1,810.38","total_whole":"1,810","shares_owned_after":9979.0,"shares_owned_after_display":"9,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-31","filed_date":"2016-08-02","scope":"insider"},{"id":2770522,"accession":"0001209191-16-094484","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-094484","line_url":"/filing/0001209191-16-094484#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":405.0,"shares_display":"405","price_per_share":4.38,"price_display":"4.38","price_state":"stated","total_value":1773.9,"total_display":"1,773.90","total_whole":"1,774","shares_owned_after":9557.0,"shares_owned_after_display":"9,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-31","filed_date":"2016-02-01","scope":"insider"},{"id":8083440,"accession":"0001209191-15-067383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-067383","line_url":"/filing/0001209191-15-067383#line-2","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.8122,"price_display":"12.81","price_state":"stated","total_value":128122.0,"total_display":"128,122.00","total_whole":"128,122","shares_owned_after":9152.0,"shares_owned_after_display":"9,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-21","scope":"insider"},{"id":8083435,"accession":"0001209191-15-067383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-067383","line_url":"/filing/0001209191-15-067383#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18656.0,"shares_display":"18,656","price_per_share":13.1969,"price_display":"13.20","price_state":"stated","total_value":246201.3664,"total_display":"246,201.37","total_whole":"246,201","shares_owned_after":19152.0,"shares_owned_after_display":"19,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-21","scope":"insider"},{"id":8751148,"accession":"0001209191-15-063680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-063680","line_url":"/filing/0001209191-15-063680#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":764.0,"shares_display":"764","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":1741.92,"total_display":"1,741.92","total_whole":"1,742","shares_owned_after":37808.0,"shares_owned_after_display":"37,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-31","filed_date":"2015-08-04","scope":"insider"},{"id":8811299,"accession":"0001209191-15-008917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-008917","line_url":"/filing/0001209191-15-008917#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8388.0,"shares_display":"8,388","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":19124.64,"total_display":"19,124.64","total_whole":"19,125","shares_owned_after":37044.0,"shares_owned_after_display":"37,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-31","filed_date":"2015-02-03","scope":"insider"},{"id":6768639,"accession":"0001209191-14-062013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-062013","line_url":"/filing/0001209191-14-062013#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.1099,"price_display":"4.11","price_state":"stated","total_value":20549.5,"total_display":"20,549.50","total_whole":"20,550","shares_owned_after":28656.0,"shares_owned_after_display":"28,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-03","filed_date":"2014-10-06","scope":"insider"},{"id":6913012,"accession":"0001209191-14-050156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-050156","line_url":"/filing/0001209191-14-050156#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8788.0,"shares_display":"8,788","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":20036.64,"total_display":"20,036.64","total_whole":"20,037","shares_owned_after":23656.0,"shares_owned_after_display":"23,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-31","filed_date":"2014-08-04","scope":"insider"},{"id":9269016,"accession":"0001209191-14-022919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-022919","line_url":"/filing/0001209191-14-022919#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.245,"price_display":"4.24","price_state":"stated","total_value":21225.0,"total_display":"21,225.00","total_whole":"21,225","shares_owned_after":14868.0,"shares_owned_after_display":"14,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2014-03-25","scope":"insider"},{"id":6376518,"accession":"0001209191-14-022903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-022903","line_url":"/filing/0001209191-14-022903#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":4.245,"price_display":"4.24","price_state":"stated","total_value":21225.0,"total_display":"21,225.00","total_whole":"21,225","shares_owned_after":14868.0,"shares_owned_after_display":"14,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2014-03-25","scope":"insider"},{"id":6521849,"accession":"0001209191-14-006705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-006705","line_url":"/filing/0001209191-14-006705#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9868.0,"shares_display":"9,868","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":22597.72,"total_display":"22,597.72","total_whole":"22,598","shares_owned_after":9868.0,"shares_owned_after_display":"9,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-31","filed_date":"2014-02-04","scope":"insider"},{"id":9268659,"accession":"0001209191-13-035773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-035773","line_url":"/filing/0001209191-13-035773#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":0.0,"shares_display":"0","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-12","filed_date":"2013-07-05","scope":"insider"},{"id":5040980,"accession":"0001209191-13-035269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-035269","line_url":"/filing/0001209191-13-035269#line-1","is_derivative":false,"issuer_cik":"0001000694","issuer_name":"NOVAVAX INC","issuer_ticker":"NVAX","issuer_name_source":null,"issuer_url":"/issuer/0001000694","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":95000.0,"total_display":"95,000.00","total_whole":"95,000","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-12","filed_date":"2013-07-03","scope":"insider"},{"id":5930415,"accession":"0001209191-09-052336","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-09-052336","line_url":"/filing/0001209191-09-052336#line-5","is_derivative":false,"issuer_cik":"0001131907","issuer_name":"MICROMET, INC.","issuer_ticker":"MITI","issuer_name_source":null,"issuer_url":"/issuer/0001131907","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Officer (SVP / Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP / Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP / Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":6.103,"price_display":"6.10","price_state":"stated","total_value":213605.0,"total_display":"213,605.00","total_whole":"213,605","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-09","filed_date":"2009-11-12","scope":"insider"},{"id":3448150,"accession":"0001179110-08-012227","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001179110-08-012227","line_url":"/filing/0001179110-08-012227","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":235000.0,"shares_display":"235,000","price_per_share":30.29820859574468,"price_display":"30.30","price_state":"stated","total_value":7120079.02,"total_display":"7,120,079.02","total_whole":"7,120,079","shares_owned_after":358801.0,"shares_owned_after_display":"358,801","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-13","filed_date":"2008-06-16","scope":"insider","n_lines":22},{"id":82171,"accession":"0001209191-03-029066","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-03-029066","line_url":"/filing/0001209191-03-029066#line-9","is_derivative":false,"issuer_cik":"0001131907","issuer_name":"CANCERVAX CORP","issuer_ticker":"CNVX","issuer_name_source":null,"issuer_url":"/issuer/0001131907","owner_cik":"0001265801","owner_name":"PHILLIPS BARCLAY A","owner_display_name":"PHILLIPS BARCLAY A","owner_url":"/insider/0001265801","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":4453.0,"shares_owned_after_display":"4,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-04","filed_date":"2003-11-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Officer (SVP & Chief Financial Officer)","n_filings":1,"first_seen":"2018-11-16","last_seen":"2018-11-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001000694","name":"NOVAVAX INC","url":"/issuer/0001000694","role":"Director, Officer (SVP, Chief Financial Officer)","n_filings":15,"first_seen":"2013-07-03","last_seen":"2017-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001131907","name":"MICROMET, INC.","url":"/issuer/0001131907","role":"Director, Officer (SVP / Chief Financial Officer)","n_filings":2,"first_seen":"2003-11-06","last_seen":"2009-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Director","n_filings":1,"first_seen":"2008-06-16","last_seen":"2008-06-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001265801","retrieved_at":"2026-08-24T16:21:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}